Patent · US Active

Ophthalmic compositions

US11439661B2 · kind B2 · utility

0Cited by
2References
19Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 25, 2020
Grant dateSep 13, 2022
Priority date
Expiry dateOct 20, 2040

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P27/04
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention is generally related to topical ophthalmic compositions comprising: from about 0.05 w/v % to about 5 w/v % of galactomannan polymer; a cis-diol and about 0.5 w/v % to about 10 w/v % of a hydrophilic copolymer which comprises (a) arylborono-containing repeating units each having a boronic acid, (b) repeating units of at least one phosphorylcholine-containing vinylic monomer, and (c) acrylic monomeric units of at least one acrylic monomer having 3 to 16 carbon atoms, the ophthalmic composition is substantially free of a borate for improving lubrication, hydration and drug delivery property.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.